CRISPR Reveals New Targets for Promising Cancer Drugs

News   Jul 20, 2017 | Original story from Harvard University

 
CRISPR Reveals New Targets for Promising  Cancer Drugs

redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had essential immune evasion genes knocked out.

 
 
 

RELATED ARTICLES

Lissencephaly Modeled in a Dish for the First Time

News

Researchers describe how cells from patients with the severe developmental disease lissencephaly differ from healthy cells. The method can provide vital new knowledge on difficult-to-study congenital diseases.

READ MORE

Discovery Provides Hope for New Vaccine Against Flesh-eating Bacteria

News

Researchers at Houston Methodist have solved a 100-year-old mystery, providing them a possible key to unlock a pathway for treating diseases caused by flesh-eating bacteria.

READ MORE

MicroRNA Helps Cancer Evade Immune System

News

Salk researchers discover how oxygen-deprived tumors survive body’s immune response.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE